Journal article icon

Journal article

Methodology for the Canadian Activase for Stroke Effectiveness Study (CASES). CASES Investigators.

Abstract:

BACKGROUND: Intravenous recombinant tissue plasminogen activator (tPA, alteplase) was conditionally licensed for the treatment of acute ischemic stroke (AIS) in Canada on February 17, 1999. As a condition of licensure, the Canadian Activase for Stroke Effectiveness Study (CASES) was established to monitor the use of alteplase for AIS in Canada. The study involves multiple stakeholders. METHODS: CASES is a prospective registry of patients treated with alteplase for AIS. The purposes of this re...

Expand abstract
Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, Stroke and Geratology
Role:
Author
Journal:
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Volume:
28
Issue:
3
Pages:
232-238
Publication date:
2001-08-05
ISSN:
0317-1671
URN:
uuid:f8d47627-fb41-4623-a258-0381a7811414
Source identifiers:
79341
Local pid:
pubs:79341

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP